 CAMBRIDGE, Mass., Sept. 28, 2021 GLOBE NEWSWIRE -- Genocea Biosciences, Inc. Nasdaq: GNCA, a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following conferences in October. 